AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Innomune Tablet

Prescription Icon
Prescription Required

Marketer

Cipla Ltd

Salt Composition

Azathioprine (50mg)

Overview Innomune Tablet

Immunosuppressant medication, TransplantGuard, is administered alongside other drugs to prevent post-transplant organ rejection (kidney, heart, liver, etc.). It's also indicated for rheumatoid arthritis management. TransplantGuard functions by reducing immune system activity, thereby minimizing the risk of organ rejection. Dosage and frequency are transplant-specific; adhere strictly to your physician's prescription. Take with food. Consistent use maximizes therapeutic benefit; continued use is crucial even with symptom improvement, as discontinuation increases organ rejection risk. Numerous side effects are possible. Common ones include appetite loss, nausea, and heightened bleeding susceptibility. Immunosuppression raises infection and cancer risk. Report any concerning side effects immediately to your doctor. TransplantGuard poses risks of birth defects and miscarriage; avoid use during pregnancy, pregnancy planning, or breastfeeding. Consult your doctor before initiating treatment if infections, unusual bruising, or bleeding occur. Full disclosure of all other medications is crucial due to potential interactions affecting TransplantGuard's efficacy. Regular blood tests will monitor blood cell counts.

Uses of Innomune Tablet

Preventing transplant organ rejection and managing rheumatoid arthritis.

Major Benefits of Innomune Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Innomune Tablets should be administered with a meal.

Common Side effects of Innomune Tablet:

  • Decreased white blood cell count
  • Increased bleeding tendency
  • Nausea
  • Infection
  • Loss of appetite

How to use Innomune Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Innomune Tablets should be taken with a meal.

How Innomune Tablet works:

Innomune tablets function as an immunosuppressant medication. By lessening the activity of the body's natural immune response, it mitigates the rejection of transplanted organs. Furthermore, it inhibits the activity of specific inflammatory mediators, thereby alleviating swelling, redness, and inflammation characteristic of some autoimmune arthritides.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Innomune Tablet lacks established safety data. Physician consultation is advised.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Innomune Tablets during pregnancy is contraindicated due to confirmed risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Innomune Tablets while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Innomune Tablet on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Innomune Tablets, as dose modification may be necessary. Individuals with severe kidney disease should avoid Innomune Tablets; consult a physician for guidance.

LiverLiverCAUTION

Patients with liver impairment should use Innomune Tablet cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates Innomune Tablet use. Physician consultation is necessary. Regular liver function assessments are recommended during treatment.

What if you forget to take Innomune Tablet :

Should you forget to take Innomune Tablet, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Innomune Tablet

LabelValue
Chemical Category Purine Nucleoside Analogs
Developing Habits No.
Treatment Category Cancer Medications
Action Class Purine analog immunosuppressants

FAQs on Innomune Tablet

Innomune Tablet is an immunosuppressant, suppressing the body's immune system. While crucial for fighting infection, an overactive immune system can cause illness. Innomune Tablet, used with other medications, treats conditions stemming from this overactivity. These include organ transplant rejection (kidney, heart, liver), chronic active hepatitis, severe rheumatoid arthritis, systemic lupus erythematosus (SLE), idiopathic thrombocytopenic purpura, and acquired hemolytic anemia. It also treats severe forms of certain skin diseases (pemphigus vulgaris, dermatomyositis, polyarteritis nodosa, pyoderma gangrenosa), particularly when corticosteroids are unsuitable.
You may not see results for 3 to 12 weeks. Keep taking the medication, even without noticeable improvement. Contact your doctor with any concerns.
Remember to take Innomune Tablet as directed. If you miss a dose, take it immediately unless it's almost time for your next dose. Never double the dose. Report frequently missed doses to your doctor.
Treatment length depends on the individual's health status.
Breastfeeding is not recommended while taking Innomune tablets due to the potential risk of serious harm to the infant.
Innomune Tablets, being immunosuppressant, may increase the risk of serious infections, low blood counts, and cancer. Report any infection or fever, unusual bleeding or bruising, black or bloody stools, or blood in your urine immediately. Also inform your doctor of any new skin sores, lumps, or changes to existing skin marks.
Innomune Tablets may decrease blood cell production, increasing infection risk and potentially affecting the liver. Regular blood tests monitor these side effects. Your doctor may order weekly blood tests (including platelet counts) for the first eight weeks, potentially reducing the frequency to monthly or every three months thereafter.
Innomune Tablet use may elevate the risk of several cancers, including skin, lymphoma, sarcoma, and cervical cancer. Minimize sun exposure and use sun protection (clothing, sunglasses, sunscreen) to reduce skin cancer risk. Report any skin changes, lumps, or masses to your doctor promptly.
Cyclosporine and Innomune Tablet can be taken together without interaction. Always follow your doctor's instructions for both medications.
Innomune Tablet
102
MRP 118
13% off